Kurs & Likviditet
Beskrivning
Land | Norge |
---|---|
Lista | OAX Equities |
Sektor | Hälsovård |
Industri | Medicinteknik |
2022-02-21 12:48:36
Oslo, February 21, 2022 - Observe Medical ASA (OSE: OBSRV) today announces a new
order for Sippi systems, from our distributor in Poland, Skamex.
Observe Medical ASA (the "Company") has today, on 21 February 2022, received an
order for 30 Sippi® Base units and 300 Sippi® Disposable units from Skamex. The
total order value for the Company is approximately EURO 10,000 as these products
will be delivered based on the initial launch period pricing agreed with Skamex,
valid until the end of the first quarter 2022. Expected delivery of the order is
late Q1 or early Q2 2022. The Company entered into the distribution agreement
with Skamex, a leading Distributor of medtech products in Poland and Romania, in
June 2021.
Sippi® is the only automated digital urine meter with the possibility for
wireless data transfer to the hospital patient data management systems and
hinders bacterial migration that can lead to urinary infections. Sippi® is CE
marked and is currently being rolled-out with focus on selected markets and
hospitals in Europe.
For further information, please contact:
Björn Larsson, CEO of Observe Medical,
Mobile: +46 76 620 17 25
E-mail: bjorn.larsson@observemedical.com
Per Arne Nygård, CFO of Observe Medical,
Mobile: +47 411 04 345
E-mail: perarne.nygard@observemedical.com
This information is considered to be inside information pursuant to the EU
Market Abuse Regulation and is subject to the disclosure requirements pursuant
to section 5-12 the Norwegian Securities Trading Act.
This stock exchange announcement was published by Per Arne Nygård, CFO of
Observe Medical ASA, on 21 February 2022 at 12:45 CET on behalf of the Company.
About Observe Medical
Observe Medical develops and markets and sells innovative hospital products that
contribute to increased patient safety and a more efficient care system. The
Company's ambition is to drive growth by leveraging its expertise in sales and
commercialization of its broad portfolio of medical technology products, mainly
in the areas of Urine measurement, Anesthesiology/ICUs, surgery and wound care,
in combination with targeted M&A. The Company is headquartered in Oslo, Norway
and its operations are based out of Gothenburg, Sweden. Observe Medical has a
direct sales organization in the Nordics and a distributor network
internationally. Sippi®, the Company's first proprietary product, is the only
automated digital urine meter with the possibility for wireless data transfer to
the hospital patient data management systems and hinders bacterial migration
that can lead to urinary infections (SippCoat®). Sippi® is CE marked and is
currently being rolled-out with a focus on selected markets and hospitals in
Europe.
Matters discussed in this announcement may constitute forward-looking
statements. Forward-looking statements are statements that are not historical
facts and may be identified by words such as "anticipate", "believe",
"continue", "estimate", "expect", "intends", "may", "should", "will" and similar
expressions. The forward-looking statements in this release are based upon
various assumptions, many of which are based, in turn, upon further assumptions.
Although the Company believes that these assumptions were reasonable when made,
these assumptions are inherently subject to significant known and unknown risks,
uncertainties, contingencies and other important factors which are difficult or
impossible to predict and are beyond its control. Such risks, uncertainties,
contingencies and other important factors could cause actual events to differ
materially from the expectations expressed or implied in this release by such
forward-looking statements. The information, opinions and forward-looking
statements contained in this announcement speak only as at its date, and are
subject to change without notice.